![](https://news.europawire.eu/wp-content/uploads/2023/05/Boehringer-Ingelheims-New-E285m-Chemical-Plant-to-Boost-Pharmaceutical-Innovation-144x144.png)
(IN BRIEF) Boehringer Ingelheim has begun construction on a new Chemical Innovation Plant at its headquarters in Ingelheim, Germany. The €285 million investment will develop manufacturing processes for active pharmaceutical ingredients and produce drugs for clinical trial phases, enabling Boehringer … Read the full press release